Pharmacodynamics of Moxifloxacin against Streptococcus pyogenes in an In Vitro Kinetic Model
The aim of the present study was to investigate the pharmacodynamics of moxifloxacin against strains of Streptococcus pyogenes with different susceptibilities to erythromycin by using an in vitro kinetic model simulating human pharmacokinetics of moxifloxacin at oral doses of 400 and 200 mg, respect...
Gespeichert in:
| Veröffentlicht in: | Antimicrob Agents Chemother |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
2002
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127214/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12019138/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.6.2046-2048.2002 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
